Qualitek Labs Ltd.

As of March 31, 2026, Qualitek Labs Ltd. carries a market capitalization of 3.60B, placing it among publicly traded companies globally. Its enterprise value stands at 4.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Qualitek Labs Ltd. has 11.65M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Qualitek Labs Ltd. maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Qualitek Labs Ltd.'s stock has gained approximately 26.19% over the past 52 weeks. The 50-day moving average sits at 518.40, while the 200-day moving average is 415.60.

As of March 31, 2026, Qualitek Labs Ltd. holds 60.48M in cash and equivalents against 936.35M in total debt, resulting in a net debt position of 844.37M. Total book value stands at 1.52B, with working capital of 25.04M providing operational flexibility.